未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma CHRONOS-4: copanlisib加利妥昔单抗为基础的免疫化疗治疗复发性惰性b细胞淋巴瘤的3期研究 Zinzani, Pier Luigi; Wang, Huaqing; Feng, Jifeng; Kim, Tae Min; Tao, Rong; Zhang, Huilai; Fogliatto, Laura; Artigal, Clara Maluquer; Ozcan, Muhit; Yanez, Eduardo; Kim, Won Seog; Kirtbaya, Dmitry; Kriachok, Iryna; Maciel, Felipe; Xue, Hongwei; Bouabdallah, Krimo; Phelps, Charles; Chaturvedi, Shalini; Weispfenning, Anke; Morcos, Peter N.; Odongo, Fatuma; Buvaylo, Viktoriya; Childs, Barrett H.; Dreyling, Martin; Matasar, Matthew; Ghione, Paola 分享 收藏
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma Nastoupil, Loretta J.; Hess, Georg; Pavlovsky, Miguel A.; Danielewicz, Iwona; Freeman, Jane; Garcia-Sancho, Alejandro Martin; Glazunova, Valeria; Grigg, Andrew; Hou, Jing-Zhou; Janssens, Ann; Kim, Seok Jin; Masliak, Zvenyslava; Mckay, Pam; Merli, Francesco; Munakata, Wataru; Nagai, Hirokazu; Ozcan, Muhit; Preis, Meir; Wang, Tingyu; Rowe, Melissa; Tamegnon, Monelle; Cir, Rui; Henninger, Todd; Curtis, Madeliene; Caces, Donne Bennett; Thieblemont, Catherine; Salles, Gilles 分享 收藏
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study Pabst, Thomas; Papayannidis, Cristina; Demirkan, Fatih; Doronin, Vadim; Fogliatto, Laura M.; Guttke, Christina; Gyan, Emmanuel; Hamad, Nada; Herrera, Pilar; Hultberg, Anna; Jacobs, Julie; Johnson, Amy J.; Langlois, Angelique; Ma, Xuewen; Martinelli, Giovanni; Arnan, Montserrat; Mueller, Rouven; Nottage, Kerri; Ofran, Yishai; Ozcan, Muhit; Samoilova, Olga; Tolbert, Jaszianne A.; Trudel, Geralyn C.; Xiu, Liang; Vey, Norbert; Wei, Andrew 分享 收藏
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data Glofitamab治疗复发/难治性弥漫性大b细胞淋巴瘤: 真实世界数据 Atesoglu, Elif Birtas; Gulbas, Zafer; Uzay, Ant; Ozcan, Muhit; Ozkalemkas, Fahir; Dal, Mehmet Sinan; Kalyon, Hakan; Akay, Olga Meltem; Deveci, Burak; Bekoz, Huseyin; Sevindik, Omur Gokmen; Toptas, Tayfur; Yilmaz, Fergun; Koyun, Derya; Alkis, Nihan; Alacacioglu, Inci; Sonmez, Mehmet; Yavasoglu, Irfan; Tombak, Anil; Mehtap, Ozgur; Kurnaz, Fatih; Yuce, Orhan Kemal; Karakus, Volkan; Turgut, Mehmet; Kurekci, Derya Deniz; Ayer, Mesut; Keklik, Muzaffer; Buyuktas, Deram; Ozbalak, Murat; Ferhanoglu, Burhan 分享 收藏
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma Wang, Michael L.; Jurczak, Wojciech; Jerkeman, Mats; Trotman, Judith; Zinzani, Pier L.; Belada, David; Boccomini, Carola; Flinn, Ian W.; Giri, Pratyush; Goy, Andre; Hamlin, Paul A.; Hermine, Olivier; Hernandez-Rivas, Jose-Angel; Hong, Xiaonan; Kim, Seok Jin; Lewis, David; Mishima, Yuko; Ozcan, Muhit; Perini, Guilherme F.; Pocock, Christopher; Song, Yuqin; Spurgeon, Stephen E.; Storring, John M.; Walewski, Jan; Zhu, Jun; Qin, Rui; Henninger, Todd; Deshpande, Sanjay; Howes, Angela; Le Gouill, Steven; Dreyling, Martin 分享 收藏
Allogeneic hematopoietic stem cell transplantation for heavily pretreated patients with mycosis fungoides and Sezary syndrome Seval, Guldane Cengiz; Sahin, Ugur; Bozdag, Sinem Civriz; Yuksel, Meltem Kurt; Topcuoglu, Pervin; Akay, Bengu Nisa; Sanli, Hatice Erdi; Gurman, Gunhan; Toprak, Selami Kocak; Ozcan, Muhit 分享 收藏
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/ refractory DLBCL: survival update and new extension cohort data Polatuzumab vedotin联合苯达莫司汀和利妥昔单抗治疗复发/难治性DLBCL: 生存更新和新的扩展队列数据 Sehn, Laurie H.; Hertzberg, Mark; Opat, Stephen; Herrera, Alex F.; Assouline, Sarit; Flowers, Christopher R.; Kim, Tae Min; McMillan, Andrew; Ozcan, Muhit; Safar, Violaine; Salles, Gilles; Ku, Grace; Hirata, Jamie; Chang, Yi Meng; Musick, Lisa; Matasar, Matthew J. 分享 收藏
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma Zinzani, Pier Luigi; Ramchandren, Radhakrishnan; Santoro, Armando; Paszkiewicz-Kozik, Ewa; Gasiorowski, Robin; Johnson, Nathalie A.; de Oliveira, Jose S. R.; Buccheri, Valeria; Perini, Guilherme Fleury; Dickinson, Michael; McDonald, Andrew; Ozcan, Muhit; Sekiguchi, Naohiro; Zhu, Ying; Raut, Monika; Saretsky, Todd L.; Nahar, Akash; Kuruvilla, John 分享 收藏
Health-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refractory classical Hodgkin lymphoma (R/R cHL) Zinzani, P. L.; Ramchandren, R.; Santoro, A.; Paszkiewicz-Kozik, E.; Gasiorowski, R.; Johnson, N. A.; de Oliveira, J. S. R.; Buccheri, V.; Perini, G. F.; Dickinson, M.; McDonald, A.; Ozcan, M.; Sekiguchi, N.; Raut, M.; Zhu, Y.; Nahar, A.; Marinello, P.; Kuruvilla, J. 分享 收藏
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience Bekoz, Huseyin; Ozbalak, Murat; Karadurmus, Nuri; Paydas, Semra; Turker, Alev; Toptas, Tayfur; Tuglular, Tulin Firatli; Altuntas, Fevzi; Cakar, Merih Kizil; Sonmez, Mehmet; Gulbas, Zafer; Demir, Nazli; Kaynar, Leylagul; Yildirim, Rahsan; Karadogan, Ihsan; Arat, Mutlu; Kapucu, Irem; Aslan, Nevin Alayvaz; Ozkocaman, Vildan; Turgut, Mehmet; Yuksel, Meltem Kurt; Ozcan, Muhit; Hacioglu, Sibel Kabukcu; Barista, Ibrahim; Demirkaya, Metin; Saydam, Guray; Toprak, Selami K.; Yilmaz, Mehmet; Demirkol, Onur; Ferhanoglu, Burhan 分享 收藏
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppae, Sirpa; Follows, George; Lenz, Georg; Kim, Won Seog; Nagler, Arnon; Dimou, Maria; Demeter, Judit; Oezcan, Muhit; Kosinova, Marina; Bouabdallah, Krimo; Morschhauser, Franck; Stevens, Don A.; Trevarthen, David; Munoz, Javier; Rodrigues, Liana; Hiemeyer, Florian; Miriyala, Ashok; Garcia-Vargas, Jose; Childs, Barrett H.; Zinzani, Pier Luigi 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
